These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8137478)

  • 1. A randomized trial of intrahepatic arterial infusion of 4'-epidoxorubicin with Lipiodol versus 4'-epidoxorubicin alone in the treatment of hepatocellular carcinoma.
    Yoshikawa M; Saisho H; Ebara M; Iijima T; Iwama S; Endo F; Kimura M; Shimamura Y; Suzuki Y; Nakano T
    Cancer Chemother Pharmacol; 1994; 33 Suppl():S149-52. PubMed ID: 8137478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase II trial of transcatheter arterial infusion chemotherapy with an epirubicin-Lipiodol emulsion for advanced hepatocellular carcinoma refractory to transcatheter arterial embolization.
    Tanaka T; Ikeda M; Okusaka T; Ueno H; Morizane C; Ogura T; Hagihara A; Iwasa S
    Cancer Chemother Pharmacol; 2008 Apr; 61(4):683-8. PubMed ID: 17541589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epirubicin-Lipiodol chemotherapy versus 131iodine-Lipiodol radiotherapy in the treatment of unresectable hepatocellular carcinoma.
    Bhattacharya S; Novell JR; Dusheiko GM; Hilson AJ; Dick R; Hobbs KE
    Cancer; 1995 Dec; 76(11):2202-10. PubMed ID: 8635022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of inoperable hepatocellular carcinoma by intra-arterial lipiodol and 4'-epidoxorubicin.
    Leung WT; Shiu WC; Leung N; Chan M; Tao M; Li AK; Metreweli C
    Cancer Chemother Pharmacol; 1992; 29(5):401-4. PubMed ID: 1312908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective regional chemotherapy of unresectable hepatic tumours using lipiodol.
    Novell JR; Dusheiko G; Markham NI; Reddy K; Dick R; Hobbs KE
    HPB Surg; 1991 Sep; 4(3):223-34; discussion 234-6. PubMed ID: 1657118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disposition of epirubicin after intraarterial administration in Lipiodol to patients with hepatocellular carcinoma.
    Dodds HM; Walpole ET; Rivory LP; Strong RW; Pond SM
    Ther Drug Monit; 1996 Oct; 18(5):537-43. PubMed ID: 8885116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interventional radiology for advanced hepatocellular carcinoma: comparison of hepatic artery infusion chemotherapy and transcatheter arterial lipiodol chemoembolization.
    Sumie S; Yamashita F; Ando E; Tanaka M; Yano Y; Fukumori K; Sata M
    AJR Am J Roentgenol; 2003 Nov; 181(5):1327-34. PubMed ID: 14573429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomised trial of targeted chemotherapy with lipiodol and 5-epidoxorubicin compared with symptomatic treatment for hepatoma.
    Madden MV; Krige JE; Bailey S; Beningfield SJ; Geddes C; Werner ID; Terblanche J
    Gut; 1993 Nov; 34(11):1598-600. PubMed ID: 8244149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated arterial infusion chemotherapy for inoperable hepatocellular carcinoma using an implantable drug delivery system.
    Iwamiya T; Sawada S; Ohta Y
    Cancer Chemother Pharmacol; 1994; 33 Suppl():S134-8. PubMed ID: 8137474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcatheter arterial chemoembolization therapy with epirubicin hydrochloride, mitomycin C-iohexol-Lipiodol emulsion (EMILE) for hepatocellular carcinoma.
    Kanematsu M
    J Gastroenterol; 1995 Apr; 30(2):215-23. PubMed ID: 7773353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study of intra-arterial infusion chemotherapy for hepatocellular carcinoma using an implantable reservoir].
    Maruo H; Kosaka A
    Gan To Kagaku Ryoho; 1993 Aug; 20(11):1473-6. PubMed ID: 8396899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Repeated arterial infusion of zinostatin stimalamer using port for advanced hepatocellular carcinoma].
    Yoshikawa M; Ebara M; Fukuda H; Sugiura N; Saisho H
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():30-3. PubMed ID: 9512684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic effect of a CDDP-epirubicin-Lipiodol emulsion on advanced hepatocellular carcinoma.
    Ichida T; Kato M; Hayakawa A; Ito S; Mori S; Sato T; Sugitani S; Sato H; Watanabe M; Asakura H
    Cancer Chemother Pharmacol; 1994; 33 Suppl():S74-8. PubMed ID: 8137488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of transcatheter arterial embolization with epirubicin-lipiodol emulsion for hepatocellular carcinoma.
    Aoyama K; Tsukishiro T; Okada K; Tsuchida T; Aiba N; Nambu S; Miyabayashi C; Yasuyama T; Higuchi K; Watanabe A
    Cancer Chemother Pharmacol; 1992; 31 Suppl():S55-9. PubMed ID: 1281046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose iodized oil transcatheter arterial chemoembolization for patients with large hepatocellular carcinoma.
    Chen MS; Li JQ; Zhang YQ; Lu LX; Zhang WZ; Yuan YF; Guo YP; Lin XJ; Li GH
    World J Gastroenterol; 2002 Feb; 8(1):74-8. PubMed ID: 11833075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective comparative study of epirubicin-lipiodol emulsion and cisplatin-lipiodol suspension for use with transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma.
    Yodono H; Matsuo K; Shinohara A
    Anticancer Drugs; 2011 Mar; 22(3):277-82. PubMed ID: 21360850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective and randomized trial of lipiodol-transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma: a comparison of epirubicin and doxorubicin (second cooperative study). The Cooperative Study Group for Liver Cancer Treatment of Japan.
    Kawai S; Tani M; Okamura J; Ogawa M; Ohashi Y; Monden M; Hayashi S; Inoue J; Kawarada Y; Kusano M; Kubo Y; Kuroda C; Sakata Y; Shimamura Y; Jinno K; Takahashi A; Takayasu K; Tamura K; Nagasue N; Nakanishi Y; Makino M; Masuzawa M; Yumoto Y; Mori T; Oda T
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-38-S6-45. PubMed ID: 9151915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Transarterial "pile-up" infusion therapy of cisplatin and lipiodol emulsion in hepatic malignancies without TAE (transcatheter arterial embolization)].
    Onohara S; Ogita M; Shimada J; Hiraki Y; Abeyama K; Nakajo M
    Gan To Kagaku Ryoho; 1992 Mar; 19(3):315-21. PubMed ID: 1311912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chemoembolization of hepatocellular carcinoma with lipiodol, epirubicin and cisplatin].
    Bokemeyer B; Grote R; Schmoll E; Freise J; Schmoll HJ; Galanski M; Schüler A; Schmidt FW
    Dtsch Med Wochenschr; 1989 Jan; 114(4):128-32. PubMed ID: 2536606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Transcatheter oily chemoembolization and intermittent hepatic artery infusion chemotherapy in the management of advanced hepatocellular carcinoma].
    Miura T; An M; Matsumoto Y; Terakado H; Murata M; Takagi S; Ikawa M; Hamada E; Watanabe K; Nakasato S
    Gan To Kagaku Ryoho; 1998 Jul; 25(9):1262-5. PubMed ID: 9703803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.